• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.内皮-间充质转化(EndoMT)在纤维性疾病发病机制中的作用。
Am J Pathol. 2011 Sep;179(3):1074-80. doi: 10.1016/j.ajpath.2011.06.001. Epub 2011 Jul 19.
2
Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).增殖性糖尿病视网膜病变中的肌成纤维细胞可起源于浸润的纤维细胞,并通过内皮-间充质转化(EndoMT)产生。
Exp Eye Res. 2015 Mar;132:179-89. doi: 10.1016/j.exer.2015.01.023. Epub 2015 Jan 28.
3
Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases.实验性诱导纤维化疾病中内皮细胞向间充质细胞转化(EndoMT)的分子机制
Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S7. doi: 10.1186/1755-1536-5-S1-S7. eCollection 2012.
4
Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?内皮-间充质转化(EndoMT)在系统性硬化症相关的肺纤维化和肺动脉高压发病机制中的作用。是神话还是现实?
Matrix Biol. 2016 Apr;51:26-36. doi: 10.1016/j.matbio.2016.01.012. Epub 2016 Jan 22.
5
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases.内皮-间充质转化(EndoMT)在人类纤维化疾病发病机制中的作用
J Clin Med. 2016 Apr 11;5(4):45. doi: 10.3390/jcm5040045.
6
Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.上皮细胞对器官纤维化的直接作用:上皮-间质转化
Hum Pathol. 2009 Oct;40(10):1365-76. doi: 10.1016/j.humpath.2009.02.020. Epub 2009 Aug 19.
7
Mechanisms of Endothelial-to-Mesenchymal Transition Induction by Extracellular Matrix Components in Pulmonary Fibrosis.肺纤维化中细胞外基质成分诱导内皮-间充质转化的机制
Bull Exp Biol Med. 2021 Aug;171(4):523-531. doi: 10.1007/s10517-021-05264-7. Epub 2021 Sep 20.
8
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.波生坦和马昔腾坦可预防系统性硬化症中的内皮-间充质转化(EndoMT):体外研究
Arthritis Res Ther. 2016 Oct 6;18(1):228. doi: 10.1186/s13075-016-1122-y.
9
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.内皮细胞向间充质转化促进系统性硬皮病的内皮功能障碍和皮肤纤维化。
Ann Rheum Dis. 2017 May;76(5):924-934. doi: 10.1136/annrheumdis-2016-210229. Epub 2017 Jan 6.
10
Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.内皮素-1(ET-1)对转化生长因子-β1诱导的内皮-间充质转化及组织纤维化的刺激作用:ET-1的一种新型促纤维化效应
PLoS One. 2016 Sep 1;11(9):e0161988. doi: 10.1371/journal.pone.0161988. eCollection 2016.

引用本文的文献

1
Uncovering the mechanistic basis of L. (rhubarb) in the treatment of chronic kidney disease: an integrative approach using network pharmacology, molecular docking, and experimental validation.揭示大黄治疗慢性肾脏病的作用机制:基于网络药理学、分子对接和实验验证的综合方法
Pharm Biol. 2025 Dec;63(1):582-606. doi: 10.1080/13880209.2025.2543829. Epub 2025 Aug 10.
2
The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary Hypertension.肺血管微环境在慢性血栓栓塞性肺动脉高压中的作用
Pulm Circ. 2025 Aug 1;15(3):e70118. doi: 10.1002/pul2.70118. eCollection 2025 Jul.
3
Tie2 activator 4E2 ameliorates diabetic nephropathy and synergizes with dapagliflozin in a mouse model.Tie2激活剂4E2可改善糖尿病肾病,并在小鼠模型中与达格列净协同作用。
Korean J Physiol Pharmacol. 2025 Sep 1;29(5):613-623. doi: 10.4196/kjpp.24.424. Epub 2025 Jul 25.
4
Identification of novel macrophages and bone morphogenetic protein signals causing ectopic calcification and impairing muscle regeneration.鉴定导致异位钙化并损害肌肉再生的新型巨噬细胞和骨形态发生蛋白信号。
iScience. 2025 Jun 9;28(7):112841. doi: 10.1016/j.isci.2025.112841. eCollection 2025 Jul 18.
5
Renal tubular epithelial cell related partial epithelial-mesenchymal transition in AAⅠ induced renal fibrosis via Wnt7b/β-catenin signaling.在AAⅠ诱导的肾纤维化中,肾小管上皮细胞相关的部分上皮-间质转化通过Wnt7b/β-连环蛋白信号传导发生。
Front Pharmacol. 2025 May 13;16:1571960. doi: 10.3389/fphar.2025.1571960. eCollection 2025.
6
The molecular determinants regulating redox signaling in diabetic endothelial cells.调节糖尿病内皮细胞氧化还原信号的分子决定因素。
Front Pharmacol. 2025 Apr 1;16:1563047. doi: 10.3389/fphar.2025.1563047. eCollection 2025.
7
Treatment of Bleomycin-induced Pulmonary Fibrosis by Intratracheal Instillation Administration of Ellagic Acid-Loaded Chitosan Nanoparticles.通过气管内滴注法给予负载鞣花酸的壳聚糖纳米颗粒治疗博来霉素诱导的肺纤维化
AAPS PharmSciTech. 2025 Mar 26;26(4):94. doi: 10.1208/s12249-025-03086-8.
8
Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases (Review).线粒体衍生肽:心血管疾病中有前景的微蛋白(综述)
Mol Med Rep. 2025 May;31(5). doi: 10.3892/mmr.2025.13492. Epub 2025 Mar 14.
9
Update of cellular senescence in kidney fibrosis: from mechanism to potential interventions.肾纤维化中细胞衰老的研究进展:从机制到潜在干预措施
Front Med. 2025 Apr;19(2):250-264. doi: 10.1007/s11684-024-1117-z. Epub 2025 Feb 27.
10
IFN-γ-mediated inhibition of JAK/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis.通过纳米灯盏花素治疗,IFN-γ介导的对JAK/STAT信号通路的抑制是改善肝纤维化的有效策略。
J Transl Med. 2025 Feb 17;23(1):195. doi: 10.1186/s12967-025-06155-5.

本文引用的文献

1
Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro.蛋白激酶Cδ和c-Abl激酶是体外转化生长因子β诱导内皮-间充质转化所必需的。
Arthritis Rheum. 2011 Aug;63(8):2473-83. doi: 10.1002/art.30317.
2
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?肾脏纤维化中的上皮-间充质转化(EMT):事实还是幻想?
J Clin Invest. 2011 Feb;121(2):468-74. doi: 10.1172/jci44595.
3
Conversion of vascular endothelial cells into multipotent stem-like cells.血管内皮细胞向多能干细胞样细胞的转化。
Nat Med. 2010 Dec;16(12):1400-6. doi: 10.1038/nm.2252. Epub 2010 Nov 21.
4
Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.系统性硬皮病中的纤维化:新出现的概念及其对靶向治疗的影响。
Autoimmun Rev. 2011 Mar;10(5):267-75. doi: 10.1016/j.autrev.2010.09.015. Epub 2010 Sep 21.
5
Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.Smad3 抑制剂阻断内皮-间充质转化可延缓链脲佐菌素诱导的糖尿病肾病的早期发展。
Diabetes. 2010 Oct;59(10):2612-24. doi: 10.2337/db09-1631. Epub 2010 Aug 3.
6
Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.内皮细胞衍生的内皮素-1 通过刺激内皮细胞向间充质转化促进糖尿病心脏中的心肌纤维化。
Circulation. 2010 Jun 8;121(22):2407-18. doi: 10.1161/CIRCULATIONAHA.110.938217. Epub 2010 May 24.
7
Fibrocytes in health and disease.纤维细胞在健康与疾病中的作用。
Exp Hematol. 2010 Jul;38(7):548-56. doi: 10.1016/j.exphem.2010.03.004. Epub 2010 Mar 18.
8
Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies.综述:纤维化疾病:细胞和分子机制及新疗法。
Ann Intern Med. 2010 Feb 2;152(3):159-66. doi: 10.7326/0003-4819-152-3-201002020-00007.
9
Epithelial-mesenchymal transitions in development and disease.发育与疾病中的上皮-间质转化
Cell. 2009 Nov 25;139(5):871-90. doi: 10.1016/j.cell.2009.11.007.
10
Pathology and pathogenesis of portal venopathy in idiopathic portal hypertension: Hints from systemic sclerosis.特发性门静脉高压症门静脉病的病理学和发病机制:系统性硬皮病的提示。
Hepatol Res. 2009 Oct;39(10):1023-31. doi: 10.1111/j.1872-034X.2009.00555.x.

内皮-间充质转化(EndoMT)在纤维性疾病发病机制中的作用。

Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.

机构信息

Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Am J Pathol. 2011 Sep;179(3):1074-80. doi: 10.1016/j.ajpath.2011.06.001. Epub 2011 Jul 19.

DOI:10.1016/j.ajpath.2011.06.001
PMID:21763673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3157273/
Abstract

The accumulation of a large number of myofibroblasts is responsible for exaggerated and uncontrolled production of extracellular matrix during the development and progression of pathological fibrosis. Myofibroblasts in fibrotic tissues are derived from at least three sources: expansion and activation of resident tissue fibroblasts, transition of epithelial cells into mesenchymal cells (epithelial-mesenchymal transition, EMT), and tissue migration of bone marrow-derived circulating fibrocytes. Recently, endothelial to mesenchymal transition (EndoMT), a newly recognized type of cellular transdifferentiation, has emerged as another possible source of tissue myofibroblasts. EndoMT is a complex biological process in which endothelial cells lose their specific markers and acquire a mesenchymal or myofibroblastic phenotype and express mesenchymal cell products such as α smooth muscle actin (α-SMA) and type I collagen. Similar to EMT, EndoMT can be induced by transforming growth factor (TGF-β). Recent studies using cell-lineage analysis have demonstrated that EndoMT may be an important mechanism in the pathogenesis of pulmonary, cardiac, and kidney fibrosis, and may represent a novel therapeutic target for fibrotic disorders.

摘要

大量肌成纤维细胞的积累是导致病理性纤维化发展和进展过程中细胞外基质过度和失控产生的原因。纤维化组织中的肌成纤维细胞至少有三个来源:固有组织成纤维细胞的扩增和激活、上皮细胞向间充质细胞的转化(上皮-间充质转化,EMT)以及骨髓来源的循环成纤维细胞的组织迁移。最近,内皮细胞向间充质细胞转化(EndoMT),一种新发现的细胞转分化类型,已成为组织肌成纤维细胞的另一个可能来源。EndoMT 是一个复杂的生物学过程,在此过程中内皮细胞失去其特定的标志物,并获得间充质或肌成纤维细胞表型,并表达间充质细胞产物,如α平滑肌肌动蛋白(α-SMA)和 I 型胶原。与 EMT 相似,转化生长因子(TGF-β)可诱导 EndoMT。最近使用细胞谱系分析的研究表明,EndoMT 可能是肺、心脏和肾脏纤维化发病机制中的一个重要机制,并可能代表纤维化疾病的一个新的治疗靶点。